Caltech’s newest Smart Pill will one day track the nanobots in your body
In the next two decades or so we will be increasingly exposed to nanobots that can perform extraordinary feats as they move around inside our bodies, but up until now there's not been any way to track them
Cite or link to this article
Griffin, M. (2017) 'Caltech’s newest Smart Pill will one day track the nanobots in your body', 311 Institute, 19 September. Available at: https://www.311institute.com/caltechs-newest-smart-pill-will-one-day-track-the-nanobots-in-your-body/ (Accessed: 8 October 2026).
The other day I made a Scouts honour pledge to the biologists and doctors among you that I'd write a piece on nanobot GPS tracking , yes, really, so here it is... In the future, if futurists like me are to be believed, hey no smirking at the back, we’re all going be quaffing both brain controlled nanobots and "regular" nanobots, that can perform surgery on us from the inside and identify diseases, like Cancer, before we show any symptoms, with our wine. Or beer. Whatever takes your fancy. However, while having all these little robotic critters roaming around our insides sounds great and all that there’s a problem with this wonderful utopian vision… how on Earth would we keep track of them all?
Well, now thanks to those spiffy guys and gals at Caltech a new chip that’s loaded with sensors and that can ping its location in the body could help us solve that issue, and one day it could be used to help us track our little friends as they meander around our insides in real time.
Open Wide and Swallow
The new chip, which could be put into a Smart Pill that could be swallowed, was inspired by MRI technology, and while we’ve already seen smart pills emerge that track gas concentrations in the intestine, and house tiny cameras, so far noone has created one that can track either itself, or other objects in vitro.
"The dream is that we will have microscale devices that are roaming our bodies and either diagnosing problems or fixing things," says Azita Emami, co-lead researcher on the study, "but before now, one of the challenges was that it was hard to tell where they are in the body."
To solve the problem the team developed a device called Addressable Transmitters Operated as Magnetic Spins (ATOMS), and the prototype measures 1.4 sq mm, or about 250 times smaller than a cent, but packed into that tiny space is a magnetic field sensor, integrated antennas, a wireless power source and a location circuit that responds to the changing magnetic field around it to beam out the chip's location in the body.
"A key principle of MRI is that a magnetic field gradient causes atoms at two different locations to resonate at two different frequencies, making it easy to tell where they are," says Mikhail Shapiro, co-lead researcher on the project, "we wanted to embody this elegant principle in a compact integrated circuit. The ATOMS devices also resonate at different frequencies depending on where they are in a magnetic field."
According to the team, it was a challenge to balance the ATOMS prototype's small size, low power consumption and location pinging accuracy, but in the end, it proved effective in tests in mice.
This early version of the device was mostly a tech demo for the tracking system, but in the long run the chips could be built into other microscale devices patrolling the body for cancer or clogged arteries.
"You could have dozens of microscale devices traveling around the body taking measurements or intervening in disease," says Shapiro, "these devices can all be identical, but the ATOMS devices would allow you to know where they all are and talk to all of them at once."
Did he say dozens of devices in our bodies? He’s thinking too small, evidently not a futurist… surely that should be millions, or billions? Anyway, since you're here, and now that I’ve tempted you with nanobots and booze could I interest you in a genetically modified synthetic beer? It’s on me, enjoy.
FAQ
Why does this matter?
In the next two decades or so we will be increasingly exposed to nanobots that can perform extraordinary feats as they move around inside our bodies, but up until now there's not been any way to track them

About the author
Matthew Griffin Founder, 311 Institute
Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath."
Read full bio
Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath." 17-time best selling author of the "Codex of the Future" series, Matthew is the Founder and Futurist in Chief of the 311 Institute, a global Futures and Deep Futures advisory firm working with royal households, world leaders, G7, G20, and G77 governments, NGOs, and multi-national mid and mega cap firms to help them explore, shape, and lead the next 50 years of business and society.
An award-winning YouTube creator with over a million followers, with an unrivalled global reach and impact, Matthew is a highly sought-after international keynote speaker, lecturer, and mentor who collaborates with global leaders through the United Nations Alliance of Civilizations (UNAOC) and United Nations General Assembly (UNGA) to shape pivotal initiatives such as the UN’s AI for Humanity program, the United Nations Conference of the Parties (UN COP), and the World Economic Forum in Davos.
As the former Global Head of Cloud, National Security, and Enterprise Sales for companies including Atos, Dell-EMC, and IBM, Matthew has a proven track record of building multi-billion dollar business units and turning failing divisions into market leaders. His ability to identify, analyse, and communicate the implications of hundreds of emerging technologies and trends is unparalleled, and his insights are trusted by many of the world’s most respected organisations, including ABB, Accenture, Adidas, AON, ARM, BCG, Centrica, Citi, Coca-Cola, Dentons, Deloitte, Dow Jones, EY, Google, KPMG, Lego, Legal & General, LinkedIn, Microsoft, PepsiCo, Qualcomm, RWE, Samsung, Siemens AG and Siemens Energy, T-Mobile, UBS, VISA, Walmart, Workday, Worldpay and many others.
Regularly featured in the global media including the AP, BBC, Bloomberg, CNBC, Discovery, Forbes, Khaleej Times, Telegraph, TIME, ViacomCBS, WIRED, and the WSJ, Matthews mission is to help organisations create a fair and sustainable future whose benefits are shared by everyone irrespective of their ability, background, or circumstances.
What future do you need to see?
Choose one to get started on computing and the future of your organisation.
Source: first published by the 311 Institute on 19 September 2017. Cite as: Griffin, M. (2017). Caltech’s newest Smart Pill will one day track the nanobots in your body. 311 Institute. https://www.311institute.com/caltechs-newest-smart-pill-will-one-day-track-the-nanobots-in-your-body/
You are welcome to quote this article with credit and a link to the original.